Sequent Scientific's Credit Ratings upgraded by India Ratings and Research

India Ratings and Research has upgraded the Company's Long-Term Issuer Rating to 'IND A' from 'IND A-' while resolving the Rating Watch Evolving (RWE). The Outlook is Positive.

SeQuent Scientific Limited (SeQuent), which has businesses across Animal Health (Alivira) & Analytical Services today announced that leading credit rating agency, India Ratings and Research has upgraded and assigned ratings 'IND A' with a 'Positive' Outlook for the Company.

Commenting on the upgrade, Manish Gupta, Managing Director, SeQuent Scientific commented, "We are pleased with the ratings upgraded by India Ratings and Research which is a recognition of SeQuent's strong financial and operating performance. Over the last 5 years, we have a six-notch improvement in our rating from BB to A, reflecting the consistent improvement in the financial performance of the Company over the period. I believe the current upgrade of SeQuent's rating with positive outlook across all classes of instruments in a challenging environment is reflective of the confidence in our unique business model with diversified revenue mix underpinned with relentless focus on execution which has transformed the Company into not only the largest from India but also amongst the 'Top 20" in the global Animal Health Industry."

Shares of SEQUENT SCIENTIFIC LTD. was last trading in BSE at Rs.155.4 as compared to the previous close of Rs. 158.4. The total number of shares traded during the day was 141676 in over 1902 trades.

The stock hit an intraday high of Rs. 162.7 and intraday low of 154.5. The net turnover during the day was Rs. 22494773.

Source : Equity Bulls

Keywords